Routine cancer screening rates rebound after deep drop from pandemic fear
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
At the beginning of the COVID-19 pandemic, the goals of minimizing viral spread in health care settings and focusing health care resources on the care of infected patients led to nonurgent medical services, such as cancer screening tests, being temporarily suspended. As a result, the sheer number of cancer screening tests, such as colonoscopies and mammograms, dropped precipitously. Little was known about the size and duration of the decline, however, and whether it would affect postpandemic adherence to guidelines for these tests.
A new study, appearing in the Journal of General Internal Medicine (2021;36:1829-1831. doi:10.1007/s11606-021-06660-5), reports that the numbers of tests are recovering, approaching pre–COVID-19 levels. The study authors believe that these results suggest that health systems were able to “recalibrate resources and protocols in a relatively short interval.”
CA: A Cancer Journal for Clinicians , résumé, 2020